FDA Drug recall D-1348-2015
univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2015-08-26
On 2015-08-26 the FDA classified a Class II recall of univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only by Ucb, citing failed Dissolution Testing: Failed 24 month dissolution testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1348-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-24 |
| Published | 2015-08-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Ucb |
| Distribution | US |
Product
univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.
Reason
Failed Dissolution Testing: Failed 24 month dissolution testing.
Identifiers
| code_info | Lot #: 98016P1, Expiry: April, 2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1348-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.